Enanta Pharmaceuticals Inc (ENTA)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $310.77M
Last updated: Nov 17, 2026 at 4:20 PM ET
Enanta Pharmaceuticals Inc (ENTA) Stock Chart
Enanta Pharmaceuticals (ENTA) has a latest price of $8.69 on Nov 17, 2026. Its price fell 27.9% over the past 12 months. The month-end price fell 54.5% over the 10 years through Oct 2026, a compound annual decline of 7.6%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $115.90 in Jun 2018 and its lowest $5.11 in Jan 2025, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart ENTA with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for ENTA.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 35.7%, and over 6 months it fell 36.8%. The month-end price rose 18.7% over the 3 years through Oct 2026, a compound annual rate of 5.9%.
| Period | Change |
|---|---|
| 1 month | -23.8% |
| 3 months | -35.7% |
| 6 months | -36.8% |
| 12 months | -27.9% |
| 12 months, with dividends | -27.9% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +18.7% | +5.9% |
| 5 years | -87.5% | -34.1% |
| 10 years | -54.5% | -7.6% |
Price by Year
Its best calendar year was 2025, when the price rose 174.3%, and its weakest was 2023, when it fell 79.8%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $10.71 | -32.1% |
| 2025 | $15.77 | +174.3% |
| 2024 | $5.75 | -38.9% |
| 2023 | $9.41 | -79.8% |
| 2022 | $46.52 | -37.8% |
| 2021 | $74.78 | +77.6% |
| 2020 | $42.10 | -31.9% |
| 2019 | $61.78 | -12.8% |
| 2018 | $70.83 | +20.7% |
| 2017 | $58.68 | +75.2% |
Trading Range
The price is 26.3% below its 50-day average of $11.78 and 33.5% below its 200-day average of $13.06.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $8.69 | |
| 50-day average | $11.78 | -26.3% |
| 200-day average | $13.06 | -33.5% |
Price Risk
Over 3 years, its largest fall from a peak was 75.6%.
| Measure | Value |
|---|---|
| 1-year beta | 1.10 |
| Largest fall, 1 year | -48.4% |
| Largest fall, 3 years | -75.6% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About ENTA
What is ENTA's 1-year price change?
Enanta Pharmaceuticals's price fell 27.9% over the past 12 months. With dividends included, the 12-month total return was -27.9%.
What is ENTA's 5-year price change?
Enanta Pharmaceuticals's month-end price fell 87.5% over the 5 years through Oct 2026, a compound annual decline of 34.1%. These figures leave out dividends.
What is ENTA's beta?
Enanta Pharmaceuticals's 1-year beta against the S&P 500 is 1.10, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 48.4%.
Is the ENTA chart free?
Yes. Advanced Charting for ENTA is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
ENTA pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors